Ghrelin injected into the paraventricular nucleus of the hypothalamus of male rats induces feeding but not penile erection

Abstract

The effect of ghrelin, a recently characterized endogenous receptor agonist for growth hormone (GH) secretagogue receptors, on feeding and penile erection was compared with that of EP 80661, a peptide analogue of the GH secretagogue hexarelin, previously identified for its pro-erectile activity when injected into the paraventricular nucleus of the hypothalamus of male rats. Ghrelin (0.01–1 μg), but not EP 80661 (0.02–1 μg), was found to be particularly effective in enhancing feeding. The minimal effective dose of ghrelin was 0.1 μg, which increased food intake by 88%, while the maximal response (355% above control values) was found with 1 μg of the peptide. The enhancing effect of ghrelin on feeding was prevented by the prior administration of the neuropeptide Y Y5 receptor antagonist ( DTyr 2, DThr 32) neuropeptide Y (NPY, 10 μg), but not by the GH-RH receptor antagonist MZ-4–71 (10 μg), or by EP 91073, a hexarelin analogue that antagonizes the pro-erectile effect of EP 80661 (10 μg), given into the lateral ventricles. In contrast, ghrelin failed to induce penile erection at all doses tested, while EP 80661 induced penile erection in a dose-dependent manner. The pro-erectile effect of EP 80661 was prevented by EP 91073 (10 μg), but not by ( DTyr 2, DThr 32) NPY (10 μg) or by the GH-RH receptor antagonist MZ 4–71 (10 μg), given into the lateral ventricles. The present results provide further support to the hypothesis that the GH secretagogue receptors mediating feeding are different from those mediating penile erection and activated by pro-erectile EP peptides.